{
  "@context": "https://schema.org/",
  "@type": "MedicalCondition",
  "@id": "aku:vascular:thrombophilia:dysfibrinogenemia",
  "name": "Dysfibrinogenemia",
  "alternateName": ["Congenital Dysfibrinogenemia", "Hereditary Dysfibrinogenemia", "Abnormal Fibrinogen"],
  "description": "Rare inherited disorder characterized by qualitatively abnormal fibrinogen that may cause bleeding, thrombosis, or remain asymptomatic. Unique among coagulation disorders in its paradoxical presentation with either hemorrhage or thrombosis depending on the specific mutation.",
  "code": [
    {
      "@type": "MedicalCode",
      "codeValue": "D68.2",
      "codingSystem": "ICD-10-CM"
    },
    {
      "@type": "MedicalCode",
      "codeValue": "267254006",
      "codingSystem": "SNOMED-CT",
      "name": "Congenital dysfibrinogenemia"
    }
  ],
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/dvt/thrombophilia",
    "type": "definition",
    "subtype": "inherited_coagulopathy",
    "difficulty": "advanced",
    "board_yield": "MODERATE"
  },
  "pathophysiology": {
    "fibrinogen_structure": {
      "genes": "FGA, FGB, FGG on chromosome 4q31",
      "structure": "Hexamer with 2 each of Aα, Bβ, and γ chains",
      "function": "Thrombin cleaves fibrinopeptides A and B to form fibrin monomers that polymerize into clot"
    },
    "inheritance": "Autosomal dominant (most cases)",
    "mutation_effects": {
      "bleeding_phenotype": "Mutations affecting fibrin polymerization or crosslinking",
      "thrombotic_phenotype": "Mutations causing impaired thrombin binding, plasminogen binding, or increased thrombin generation",
      "asymptomatic": "Many mutations have no clinical consequence"
    },
    "phenotype_distribution": {
      "asymptomatic": "55%",
      "bleeding": "25%",
      "thrombosis": "10-20%",
      "both_bleeding_and_thrombosis": "Rare (<5%)"
    }
  },
  "clinical_features": {
    "bleeding_manifestations": [
      "Postoperative bleeding",
      "Post-traumatic bleeding",
      "Menorrhagia",
      "Postpartum hemorrhage",
      "Mucocutaneous bleeding"
    ],
    "thrombotic_manifestations": [
      "Deep vein thrombosis",
      "Pulmonary embolism",
      "Arterial thrombosis (less common)",
      "Recurrent pregnancy loss"
    ],
    "pregnancy_complications": [
      "Recurrent miscarriage",
      "Placental abruption",
      "Postpartum hemorrhage",
      "Thromboembolism"
    ],
    "wound_healing": "Impaired wound healing in some variants"
  },
  "diagnosis": {
    "laboratory": {
      "screening_tests": {
        "thrombin_time": "Prolonged (most sensitive screening test)",
        "reptilase_time": "Prolonged (not affected by heparin)",
        "pt_aptt": "May be normal or prolonged"
      },
      "fibrinogen_discrepancy": {
        "functional_fibrinogen": "Low (Clauss method)",
        "antigenic_fibrinogen": "Normal",
        "interpretation": "Discrepancy between functional and antigenic levels is key diagnostic clue"
      }
    },
    "confirmatory": "Genetic testing for FGA, FGB, FGG mutations",
    "differential": [
      "Afibrinogenemia (absent fibrinogen)",
      "Hypofibrinogenemia (low fibrinogen)",
      "Acquired dysfibrinogenemia (liver disease)"
    ]
  },
  "management": {
    "general_principles": {
      "asymptomatic": "No treatment required, genetic counseling",
      "bleeding_phenotype": "Fibrinogen replacement for procedures/bleeding",
      "thrombotic_phenotype": "Anticoagulation for acute events"
    },
    "fibrinogen_replacement": {
      "sources": [
        "Cryoprecipitate (10-15 mL/kg)",
        "Fibrinogen concentrate (RiaSTAP) 70 mg/kg",
        "Fresh frozen plasma"
      ],
      "target": "Fibrinogen >100 mg/dL for procedures, >150 mg/dL for major surgery"
    },
    "surgery_perioperative": {
      "bleeding_phenotype": "Fibrinogen replacement before and after",
      "thrombotic_phenotype": "Balance thrombosis prevention with bleeding risk"
    },
    "pregnancy": {
      "monitoring": "Serial fibrinogen levels",
      "delivery": "Fibrinogen replacement if levels low",
      "postpartum": "Monitor for both bleeding and thrombosis"
    }
  },
  "clinical_pearls": [
    "Thrombin time is most sensitive screening test - always prolonged in dysfibrinogenemia",
    "Discrepancy between functional (low) and antigenic (normal) fibrinogen = dysfibrinogenemia",
    "Same mutation can cause different phenotypes in family members - variable expressivity",
    "Most cases are asymptomatic - discovered incidentally on routine coagulation testing"
  ],
  "semantic_relations": {
    "broader": ["aku:vascular:thrombophilia:inherited"],
    "narrower": [],
    "related": [
      "aku:vascular:bleeding:fibrinogen-disorders",
      "aku:vascular:surgery:perioperative-hemostasis",
      "aku:vascular:dvt:inherited-thrombophilia"
    ]
  },
  "learning_objectives": [
    "Explain how dysfibrinogenemia can cause both bleeding and thrombosis",
    "Describe the laboratory findings characteristic of dysfibrinogenemia",
    "Outline management strategies for different dysfibrinogenemia phenotypes"
  ],
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-06T01:40:00.000Z",
    "updated": "2026-01-06T01:40:00.000Z",
    "contributors": ["copilot"],
    "status": "validated",
    "confidence": 0.95
  }
}
